Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Y Merrouche

Showing results (31-40 of 60) with videos related to

Pageof 6
Sort By:
Bulletin Du Cancer|January 1, 1992
[Analysis of changes in serum levels of TNF, IL-1 and IL-6 during administration of IL-2. Correlation with clinical response to treatment]J Y Blay, S Négrier, V Combaret, et al.
Journal De Chirurgie|June 1, 1992
[Treatment of cancer of the kidney with interleukin 2 in adults, the Lyon experience]S Negrier, A Mercatello, B Coronel, et al.
Gastroenterologie Clinique Et Biologique|December 1, 1989
[Effect of azidothymidine on cryptosporia diarrhea in a patient with acquired immunodeficiency syndrome]P Sogni, P Coutarel, S Chaussade, et al.
Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy|January 1, 1995
Intensive regimen of cytokines with interleukin-2 and interferon alfa-2b in selected patients with metastatic renal carcinomaS Négrier, A Mercatello, M Bret, et al.
Targeted Oncology|April 24, 2013
Phase II study assessing lapatinib added to letrozole in patients with progressive disease under aromatase inhibitor in metastatic breast cancer-Study BES 06C Villanueva, G Romieu, J Salvat, et al.
Bulletin Du Cancer|July 1, 1993
[Treatment with cytokines of metastatic kidney cancer: the Lyon experience]S Négrier, A Mercatello, B Coronel, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1995
Phase I study of RP 49532A, a new protein-synthesis inhibitor, in patients with advanced refractory solid tumorsG Catimel, R Coquard, J P Guastalla, et al.
British Journal of Cancer|November 1, 1993
Patients with metastatic renal carcinoma candidate for immunotherapy with cytokines. Analysis of a single institution study on 181 patientsT Philip, S Negrier, C Lasset, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1995
Clinical application of retroviral gene transfer in oncology: results of a French study with tumor-infiltrating lymphocytes transduced with the gene of resistance to neomycinY Merrouche, S Negrier, C Bain, et al.
Bone Marrow Transplantation|October 1, 1991
Intravenous interleukin-2 just after high dose BCNU and autologous bone marrow transplantation. Report of a multicentric French pilot studyS Negrier, J Y Ranchere, I Philip, et al.
Pageof 6

Showing results (31-40 of 60) with videos related to

Sort By:
Pageof 6
Bulletin Du Cancer|January 1, 1992
[Analysis of changes in serum levels of TNF, IL-1 and IL-6 during administration of IL-2. Correlation with clinical response to treatment]J Y Blay, S Négrier, V Combaret, et al.
Journal De Chirurgie|June 1, 1992
[Treatment of cancer of the kidney with interleukin 2 in adults, the Lyon experience]S Negrier, A Mercatello, B Coronel, et al.
Gastroenterologie Clinique Et Biologique|December 1, 1989
[Effect of azidothymidine on cryptosporia diarrhea in a patient with acquired immunodeficiency syndrome]P Sogni, P Coutarel, S Chaussade, et al.
Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy|January 1, 1995
Intensive regimen of cytokines with interleukin-2 and interferon alfa-2b in selected patients with metastatic renal carcinomaS Négrier, A Mercatello, M Bret, et al.
Targeted Oncology|April 24, 2013
Phase II study assessing lapatinib added to letrozole in patients with progressive disease under aromatase inhibitor in metastatic breast cancer-Study BES 06C Villanueva, G Romieu, J Salvat, et al.
Bulletin Du Cancer|July 1, 1993
[Treatment with cytokines of metastatic kidney cancer: the Lyon experience]S Négrier, A Mercatello, B Coronel, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1995
Phase I study of RP 49532A, a new protein-synthesis inhibitor, in patients with advanced refractory solid tumorsG Catimel, R Coquard, J P Guastalla, et al.
British Journal of Cancer|November 1, 1993
Patients with metastatic renal carcinoma candidate for immunotherapy with cytokines. Analysis of a single institution study on 181 patientsT Philip, S Negrier, C Lasset, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1995
Clinical application of retroviral gene transfer in oncology: results of a French study with tumor-infiltrating lymphocytes transduced with the gene of resistance to neomycinY Merrouche, S Negrier, C Bain, et al.
Bone Marrow Transplantation|October 1, 1991
Intravenous interleukin-2 just after high dose BCNU and autologous bone marrow transplantation. Report of a multicentric French pilot studyS Negrier, J Y Ranchere, I Philip, et al.
Pageof 6